Sei Investments CO Reata Pharmaceuticals Inc Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $2.34 Million - $3.11 Million	29,529 Added 238.89%	41,890 $4.27 Million
Q1 2023 May 12, 2023	SELL	$30.85 - $93.17 $279,655 - $844,586	-9,065 Reduced 42.31%	12,361 $1.12 Million
Q4 2022 Feb 10, 2023	BUY	$22.15 - $42.11 $474,585 - $902,248	21,426 New	21,426 $813,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $185,442 - $803,461	-7,241 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $9,500 - $13,586	-95 Reduced 1.29%	7,241 $746,000
Q2 2021 Aug 06, 2021	SELL	$78.27 - $151.29 $18,863 - $36,460	-241 Reduced 3.18%	7,336 $1.07 Million
Q1 2021 May 12, 2021	SELL	$94.25 - $132.81 $31,196 - $43,960	-331 Reduced 4.19%	7,577 $835,000
Q4 2020 Feb 08, 2021	BUY	$102.03 - $184.62 $325,883 - $589,676	3,194 Added 67.76%	7,908 $963,000
Q3 2020 Dec 04, 2020	SELL	$93.53 - $163.34 $280 - $490	-3 Reduced 0.06%	4,714 $457,000
Q3 2020 Nov 06, 2020	SELL	$93.53 - $163.34 $18,799 - $32,831	-201 Reduced 4.09%	4,717 $457,000
Q2 2020 Aug 17, 2020	BUY	$126.3 - $176.56 $378,773 - $529,503	2,999 Added 156.28%	4,918 $767,000
Q2 2020 Aug 11, 2020	SELL	$126.3 - $176.56 $477,792 - $667,926	-3,783 Reduced 66.35%	1,919 $391,000
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $119,193 - $237,830	960 Added 20.24%	5,702 $821,000
Q4 2019 Feb 06, 2020	BUY	$74.57 - $217.92 $353,610 - $1.03 Million	4,742 New	4,742 $971,000
Q3 2019 Nov 12, 2019	SELL	$71.26 - $95.75 $375,896 - $505,081	-5,275 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $170,362 - $206,815	-2,192 Reduced 29.36%	5,275 $494,000
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $62,176 - $121,944	-1,198 Reduced 13.83%	7,467 $635,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $422,505 - $662,352	8,665 New	8,665 $486,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account